Walgreen's Target, Estimates Boosted at UBS (WAG)

Walgreen’s Target, Estimates Boosted at UBS (WAG)


Drugstore chain operator Walgreen Company (WAG) on Wednesday caught some positive commentary from analysts at UBS.

The firm maintained its “Buy” rating on WAG and lifted its price target to $39, suggesting a 12% upside to the stock’s Tuesday closing price of $34.80. UBS also raised its earnings estimates for the company, noting it expects a deal with ExpressScripts (ESRX) to happen in April or May. As a result, the analyst believes the risk/reward balance has skewed to the upside for the stock.

Walgreen shares, which have risen 5% year-to-date, were unchanged in premarket trading Wednesday.

The Bottom Line
Shares of Walgreen Company (WAG) have a 2.59% dividend yield, based on last night’s closing stock price of $34.80. The stock has technical support in the $31-$32 price area. If the shares can firm up, we see overhead resistance around the $36-$38 price levels.

Walgreen Company (WAG) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.3 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

Free Updates

Join over 100,000 investors who get the latest news from Dividend.com.

Best Dividend Stocks

Looking for stocks that are poised for growth and pay solid dividends? Visit our list of the:

Best Dividend Stocks

14 Day Free Trial

Earn more from your dividend portfolio within the next 14 days.

Sign Up Today